Jeronimo
Martinez Garcia
Asociado Ciencias de la Salud
Publications (31) Publications de Jeronimo Martinez Garcia
2024
-
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
The Lancet, Vol. 403, Núm. 10421, pp. 31-43
-
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Gynecologic Oncology, Vol. 185, pp. 202-211
-
Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience from 2 Tertiary Referral Centers
Actas Dermo-Sifiliograficas
-
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study
BMC Cancer, Vol. 24, Núm. 1
-
Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition
Annals of Surgical Oncology, Vol. 31, Núm. 10, pp. 7157-7164
2023
-
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 30, pp. 4768-4778
-
Exercise during treatment for advanced cervical cancer
BMJ Supportive and Palliative Care, Vol. 13, Núm. e3, pp. E960-E963
-
HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric Survey
Cancers, Vol. 15, Núm. 13
-
Incidence Trends and Main Features of Gastro-Intestinal Stromal Tumours in a Mediterranean Region: A Population-Based Study
Cancers, Vol. 15, Núm. 11
-
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Journal of Clinical Oncology
-
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A
Signal Transduction and Targeted Therapy, Vol. 8, Núm. 1
-
SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2707-2717
2022
-
Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflections
Clinical and Translational Oncology, Vol. 24, Núm. 8, pp. 1542-1548
2021
-
A growth modulation index-based geistra score as a new prognostic tool for trabectedin efficacy in patients with advanced soft tissue sarcomas: A Spanish group for sarcoma research (GEIS) retrospective study
Cancers, Vol. 13, Núm. 4, pp. 1-15
-
Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used
Langenbeck's Archives of Surgery, Vol. 406, Núm. 7, pp. 2449-2456
-
CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients
OncoImmunology, Vol. 10, Núm. 1
-
Characteristics and prognosis of jejunoileal gastrointestinal stromal tumours (GISTs) in the era of imatinib: a comparative study with gastric GISTs
Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1368-1376
-
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers
European urology oncology, Vol. 4, Núm. 2, pp. 246-255
-
SEOM clinical guideline in ovarian cancer (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 961-968
-
Unresectable GIST liver metastases and liver transplantation: A review and theoretical basis for a new indication
International Journal of Surgery, Vol. 94